TherapeuticsMD
TXMD
$1.17
Share price
-1.68%
Change (1 day)
-32.37%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Total debt
Total debt on the balance sheet as of March 2025 : $6.97 Million USD
According to TherapeuticsMD's latest financial reports the company's total debt is $6.97 Million USD. A company’s total debt is the sum of all current and non-current debts.
TherapeuticsMD - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $8.75 M | -95.57% |
| 2021-12-31 | $0.19 B | -20.49% |
| 2020-12-31 | $0.24 B | 21.12% |
| 2019-12-31 | $0.20 B | 179.75% |
| 2018-12-31 | $73.38 M | |
| 2012-12-31 | $3.58 M | 52.73% |
| 2011-12-31 | $2.35 M | 211.87% |
| 2010-12-31 | $0.75 M | 25.59% |
| 2009-12-31 | $0.6 M | |
| 2005-12-31 | $0.08 M | |
| 1998-12-31 | $0.02 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | $0.28 M | -95.85% | 🇺🇸 USA |
 Lannett Company LCI | $0.63 B | 9,075.56% | 🇺🇸 USA |
 Pfizer PFE | $61.29 B | 879,128.23% | 🇺🇸 USA |
 AbbVie ABBV | $69.88 B | 1,002,467.78% | 🇺🇸 USA |
 Royalty Pharma RPRX | $7.61 B | 109,173.42% | 🇬🇧 UK |